This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
Balance Sheets
Balance Sheets (Parenthetical)
Statements of Operations
Statements Of Comprehensive Income (Loss)
Statements of Cash Flows
Notes to Financial Statements
Business
Summary of Significant Accounting Policies
Capitalization
Net Income (Loss) Per Common Share
Cash, Cash Equivalents and Available for Sale Securities
Licensing and Commercialization Agreement with Novartis Pharma AG
Financing Agreement with Novo A/S
Income Taxes
Fair Value Measurements
Stock Option and Compensation Plans
Property and Equipment
Restatement of Previously Issued Financial Statements
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Net Income (Loss) Per Common Share (Tables)
Cash, Cash Equivalents and Available for Sale Securities (Tables)
Licensing and Commercialization Agreement with Novartis Pharma AG (Tables)
Fair Value Measurements (Tables)
Stock Option and Compensation Plans (Tables)
Property and Equipment (Tables)
Notes Details
Summary of Significant Accounting Policies (Detail)
Summary of Significant Accounting Policies (Details 2)
Summary of Significant Accounting Policies (Details 3)
Capitalization (Details)
Net Income (Loss) Per Common Share (Details)
Cash, Cash Equivalents and Available for Sale Securities (Details)
Licensing and Commercialization Agreement with Novartis Pharma AG (Details)
Financing Agreement with Novo A/S (Details)
Fair Value Measurements (Details)
Stock Option and Compensation Plans (Details)
Stock Option and Compensation Plans (Details 2)
Stock Option and Compensation Plans (Details 3)
Property and Equipment (Details)
All Reports
Rendering Log